Skip to main content
Top
Published in: Cellular Oncology 6/2022

24-11-2022 | Colorectal Cancer | Correction

Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution

Authors: Guanglong Chen, Ting Gong, Zhe Wang, Zeyu Wang, Xiaolin Lin, Sunrui Chen, Chu Sun, Weijie Zhao, Ye Kong, Huihan Ai, Hang Yang, Yusheng Liu, Fangyan Wu, Jiawei Kang, Shasha Zhao, Xiuying Xiao, Jing Sun, Aina He, Zhi Li

Published in: Cellular Oncology | Issue 6/2022

Login to get access

Excerpt

Correction to: Cellular Oncology
Metadata
Title
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution
Authors
Guanglong Chen
Ting Gong
Zhe Wang
Zeyu Wang
Xiaolin Lin
Sunrui Chen
Chu Sun
Weijie Zhao
Ye Kong
Huihan Ai
Hang Yang
Yusheng Liu
Fangyan Wu
Jiawei Kang
Shasha Zhao
Xiuying Xiao
Jing Sun
Aina He
Zhi Li
Publication date
24-11-2022
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 6/2022
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-022-00728-y

Other articles of this Issue 6/2022

Cellular Oncology 6/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine